ChartMillAugust 14, 2026 at 6:11 AM NY21 days ago

Arcutis Biotherapeutics (NASDAQ:ARQT) Matches Navellier's Growth Playbook With Accelerating Fundamentals

Arcutis Biotherapeutics (ARQT) fits Louis Navellier's 8 growth rules—strong earnings, sales, margins, cash flow, and ROE.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — ChartMill

Companies in This Story